Novolizer: a multidose dry powder inhaler.

Abstract

Novolizer is a multidose breath-actuated dry powder inhaler (DPI) approved for use with salbutamol (albuterol) and budesonide. It has multiple patient feedback mechanisms and an inspiratory flow rate threshold designed to optimise dosage. In two studies, children aged 4-11 years with asthma correctly used Novolizer and generated mean peak inspiratory flow… (More)

Topics

Cite this paper

@article{Fenton2003NovolizerAM, title={Novolizer: a multidose dry powder inhaler.}, author={Caroline Fenton and Gillian M. Keating and Greg L. Plosker}, journal={Drugs}, year={2003}, volume={63 22}, pages={2437-45; discussion 2447-8} }